Goldman Sachs raises its gold price target to $4,900 by end-2026
Investors following the latest maneuvers from Cathie Wood’s ARK ETFs found a mix of strategic buys and sells on Monday, October 6th, 2025, with significant moves that may signal the firm’s evolving market outlook. Leading the day’s trades was a substantial investment in DoorDash Inc (NYSE:DASH), with ARK purchasing a total of 25,581 shares across its ARKQ and ARKX ETFs, amounting to a hefty $6,938,078.
In another notable transaction, ARK increased its stake in Deere & Co (NYSE:DE) by acquiring 7,274 shares through its ARKQ ETF, with a total value of $3,366,989. This purchase continues ARK’s recent pattern of bolstering its position in the agricultural machinery company, following a smaller buy last week.
On the sell side, ARK divested a total of 180,169 shares of Adaptive Biotechnologies Corp (NASDAQ:ADPT) from its ARKG ETF, totaling $2,590,830. This move might reflect a shift in ARK’s investment strategy regarding the biotech sector.
A significant sale also occurred with AeroVironment Inc (NASDAQ:AVAV), where ARK sold 13,969 shares, splitting the transaction between its ARKQ and ARKX ETFs, resulting in a collective sale worth $5,233,346.
Additionally, ARK’s ARKK ETF bought 4,449 shares of Alibaba Group Holding Ltd (NYSE:BABA), investing $836,545. This trade is part of a series of consistent buys into Alibaba, suggesting ARK’s growing confidence in the e-commerce giant despite broader market uncertainties.
Other purchases included L3Harris Technologies Inc (NYSE:LHX) and MercadoLibre Inc (NASDAQ:MELI), with respective dollar values of $5,797,023 and $3,780,585, showing ARK’s appetite for defense and e-commerce sectors.
Conversely, ARK offloaded shares in Kratos Defense and Security Solutions Inc (NASDAQ:KTOS), Rocket Lab Corp (NASDAQ:RKLB), and Brera Holdings PLC (NYSE:SLMT), with total values of $5,561,321, $4,848,068, and $1,353,472, respectively. These sales may indicate a strategic repositioning or profit-taking within these sectors.
Lastly, ARK’s ARKG ETF bought 19,875 shares of GeneDx Holdings Corp (NASDAQ:WGS) at a value of $2,350,417, reinforcing its interest in genomic innovation.
Investors and market spectators will likely keep a close eye on ARK’s dynamic trading approach, as each buy and sell provides fresh insights into Cathie Wood’s vision of future market trends.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.